Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Radiation Oncology/Therapy
Radiation Oncology access program reduces racial disparities
Researchers are highlighting the success of a same-day radiation oncology access initiative that reduced racial disparities.
September 18, 2023
Tailored SABR for lung cancer reduces radiation dose
Tailored SABR for lung cancer translates to lower radiation dose.
September 14, 2023
FAPI-PET/CT may improve treatment of cancer patients
Gallium-68 (Ga-68) FAPI-PET/CT imaging -- a highly accurate experimental approach for detecting cancer -- may further improve outcomes for patients undergoing radiation therapy, according to a recent analysis by German researchers.
September 11, 2023
Eczacıbaşı-Monrol to expand Lu-177 production
Turkish radiopharmaceutical company Eczacıbaşı-Monrol plans to expand its Lutetium-177 (Lu-177) production capacity.
September 10, 2023
Blue Earth highlights prostate cancer preclinical results
Blue Earth Therapeutics is highlighting results from a preclinical study evaluating the efficacy of Ac-225 rhPSMA-10.1 compared with Lu-177 rhPSMA-10.1 for the treatment of prostate cancer.
September 10, 2023
ASTRO president speaks at cancer panel
Jeff Michalski, MD, president of the American Society for Radiation Oncology (ASTRO), spoke at the recent President's Cancer Panel, part of the Biden Administration's National Cancer Plan.
September 6, 2023
Actinium to present three abstracts at SOHO 2023
Radiotherapy developer Actinium Pharmaceuticals will present three abstracts accepted for poster presentation at the Society of Hematologic Oncology (SOHO) 2023 annual meeting in Houston, TX, between September 6 and 9.
August 30, 2023
TerraPower, PanTera sign agreement for Ac-225 production
TerraPower Isotopes and PanTera signed a strategic collaboration that they say will increase the global availability of actinium-225 (Ac-225), a radioisotope that may prove able to treat a large variety of cancer indications.
August 30, 2023
UF Health Proton Therapy Institute completes $44M expansion
The University of Florida (UF) Health Proton Therapy Institute has completed a $44Â million expansion and upgrade project that it began in 2016.
August 29, 2023
RaySearch posts second-quarter, half-year revenue increases
RaySearch has posted second-quarter and half-year revenue increases for the period.
August 27, 2023
First patient treated in NorthStar/Clarity clinical trial
The first patient has been treated using NorthStar Medical Radioisotopes' electron accelerator-generated copper-67 (Cu-67) radioisotope in Clarity Pharmaceutical's U.S.-based SARTATE peptide receptor radionuclide therapy trial.
August 27, 2023
CLS Americas inks partnership with Focalyx
Clinical Laserthermia Systems (CLS) Americas has inked a comarketing agreement with Focalyx for image-guided focal laser ablation of prostate tumors.
August 27, 2023
Page 1 of 459
Next Page